Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
about
Self and nonself: how autophagy targets mitochondria and bacteriaSystemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1, -6, and -9 in neonatal dogs.Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivoDuchenne muscular dystrophy gene therapy in the canine model.Prediction of adeno-associated virus neutralizing antibody activity for clinical application.Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8.Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.Humoral Immune Response to AAV.An emerging adeno-associated viral vector pipeline for cardiac gene therapyDirect interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applicationsSweating the small stuff: Glycoproteins in human sweat and their unexplored potential for microbial adhesion.Systemic delivery of adeno-associated viral vectors.Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysatesCell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV).C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.Viral Vectors, Engineered Cells and the CRISPR Revolution.AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement.Pharmacology of Recombinant Adeno-associated Virus Production.AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
P2860
Q27012602-B4718683-E2D4-4398-986B-2273004A90C6Q34001776-0BDA88EC-E6FB-455D-A216-E2DA08D10E2AQ34321271-34E6748F-1406-4428-835F-6DE3129CDCACQ34629995-A1519B89-A48C-48B4-8673-0CECED5D76ABQ35641673-6128F58E-0C6C-43F4-9BE4-253CAC0F5585Q36348346-B4643F92-799D-4114-B2C7-2C1421FCD780Q36945722-D4C344CB-3F76-4174-BF4F-8BC88EB25F3FQ37011792-11BBDF5A-B289-4516-9696-D0DE63B24ED8Q37236099-7A1EA6A7-89E7-48A0-89D1-5D8FB62D4A6AQ37272838-E6D18CA3-F1BD-4B43-AB5A-050840549592Q37609090-FF2CEC1F-8736-44A8-80D8-62A6A421F72AQ38638082-DA86FFDF-D73C-4700-AAA7-B0BCB0D1F46BQ38908933-33D7BFE9-85A7-4F26-B2A1-FB46C7DB42D3Q39039286-651FB56E-B240-4874-8A76-8C3CE372E3E1Q40445311-BF7AE219-56FA-4A1D-B613-25125CBCC2A6Q42030992-4582475B-11FF-404B-9F54-120B966DE910Q45874356-DAE20DDA-E497-4163-B3AF-E345881AC6D6Q49894243-718A96FA-385C-4EB7-9A03-31880B73A729Q52717185-F4BE5A32-6684-4D31-8748-FBC3F619BD06Q58795206-744A8616-E47C-4EAA-939D-B023A792E550
P2860
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@ast
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@en
type
label
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@ast
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@en
prefLabel
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@ast
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@en
P2093
P2860
P356
P1433
P1476
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6
@en
P2093
Aravind Asokan
Cyriaque Beley
Fedor Svinartchouk
Jerome Denard
Luis Garcia
Philippe Moullier
R Jude Samulski
René Lai-Kuen
Robert Kotin
P2860
P304
P356
10.1128/JVI.00297-12
P407
P577
2012-04-11T00:00:00Z